NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Biotherapy Services

Biotherapy Services

Private
LondonHealthcare & Life Scienceshttps://biotherapyservices.com/

Last Round

Series A

Extension

Jul 8, 2021

Total Funding Raised

$5.93M

Company Overview

Biotherapy Services is a biopharmaceutical company that develops regenerative therapies for wound care. The company's main product is RAPID™ Biodynamic Haematogel, a wound treatment for complex wounds like diabetic foot ulcers, which uses a patient's own blood to accelerate healing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

autologous biotherapywound healingregenerative medicinediabetic foot ulcersadvanced wound careplatelet-rich plasmaPRPchronic wound treatmentcell therapypoint of care therapytissue regenerationclinical trialsGMP manufacturingnamed-patient accessInnovative Licensing and Access PathwayILAP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biotherapy Services Comparables

Compare Biotherapy Services with similar companies based on industry and business-model similarity.

Biotherapy Services comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RedDress
77%
Nuo Therapeutics Inc
64%
RION
63%

Biotherapy Services Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJul 8, 2021
Series ANov 12, 2019

Biotherapy Services Investors

Notable investors and investment history

Biotherapy Services investors
InvestorRounds
Foresight Enterprise VCTSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 2, 2025

    Monthly visitors grew 737% MoM, from 215 to 1.8K.

  • Jul 8, 2021

    $2M round led by Foresight Group Holdings plc

Biotherapy Services Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Biotherapy Services Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biotherapy Services's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range4
Year Founded2013
Last FundingJul 8, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.